OncoTargets and Therapy

ISSN: 1178-6930

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Case Series

Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series

Shimbu K, Hisakane K, Kadoma N, Nishima S, Atsumi K, Seike M, Hirose T

OncoTargets and Therapy 2024, 17:717-726

Published Date: 29 August 2024

Review

Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy

Prodi E, Neri D, De Luca R

OncoTargets and Therapy 2024, 17:697-715

Published Date: 29 August 2024

Review

KRASG12C Inhibitors in Non-Small Cell Lung Cancer: A Review

Tang M, Wu Y, Bai X, Lu Y

OncoTargets and Therapy 2024, 17:683-695

Published Date: 24 August 2024

Original Research

A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis

Valente M, Colucci M, Vegni V, Croce V, Bellan C, Rossi G, Gibilisco G, Frongia F, Guazzo R, Ghiribelli C, Bargagli E, Savelli V, Ravara M, Sani T, Simonetti E, Maio M, Calabrò L, Di Giacomo AM

OncoTargets and Therapy 2024, 17:673-681

Published Date: 22 August 2024

Case report

Combination of Sintilimab and Anlotinib for Metastatic Osteosarcoma: A Case Report

Tang G, Zhang Q, Wang F, Zhang H, Qi Y

OncoTargets and Therapy 2024, 17:661-665

Published Date: 13 August 2024